Follow
Aysegul Sahin
Aysegul Sahin
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata, KH Lan, X Zhou, M Tan, FJ Esteva, AA Sahin, KS Klos, P Li, ...
Cancer cell 6 (2), 117-127, 2004
22812004
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
H Zhou, J Kuang, L Zhong, W Kuo, J Gray, A Sahin, B Brinkley, S Sen
Nature genetics 20 (2), 189-193, 1998
16371998
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in …
AU Buzdar, NK Ibrahim, D Francis, DJ Booser, ES Thomas, RL Theriault, ...
Journal of clinical oncology 23 (16), 3676-3685, 2005
15132005
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
L Zhang, S Zhang, J Yao, FJ Lowery, Q Zhang, WC Huang, P Li, M Li, ...
Nature 527 (7576), 100-104, 2015
12202015
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
K Stemke-Hale, AM Gonzalez-Angulo, A Lluch, RM Neve, WL Kuo, ...
Cancer research 68 (15), 6084-6091, 2008
12122008
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics
BT Hennessy, AM Gonzalez-Angulo, K Stemke-Hale, MZ Gilcrease, ...
Cancer research 69 (10), 4116-4124, 2009
10632009
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
CW Li, SO Lim, W Xia, HH Lee, LC Chan, CW Kuo, KH Khoo, SS Chang, ...
Nature communications 7 (1), 12632, 2016
9772016
IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway
DF Lee, HP Kuo, CT Chen, JM Hsu, CK Chou, Y Wei, HL Sun, LY Li, ...
Cell 130 (3), 440-455, 2007
8262007
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
JY Yang, CS Zong, W Xia, H Yamaguchi, Q Ding, X Xie, JY Lang, CC Lai, ...
Nature cell biology 10 (2), 138-148, 2008
8102008
Benign breast diseases: classification, diagnosis, and management
M Guray, AA Sahin
The oncologist 11 (5), 435-449, 2006
7332006
Deubiquitination and stabilization of PD-L1 by CSN5
SO Lim, CW Li, W Xia, JH Cha, LC Chan, Y Wu, SS Chang, WC Lin, ...
Cancer cell 30 (6), 925-939, 2016
6802016
The 2019 WHO classification of tumours of the breast
PH Tan, I Ellis, K Allison, E Brogi, SB Fox, S Lakhani, AJ Lazar, EA Morris, ...
Histopathology 77 (2), 2020
6522020
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer
KM Vasudevan, DA Barbie, MA Davies, R Rabinovsky, CJ McNear, ...
Cancer cell 16 (1), 21-32, 2009
6302009
Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
S Zhang, WC Huang, P Li, H Guo, SB Poh, SW Brady, Y Xiong, LM Tseng, ...
Nature medicine 17 (4), 461-469, 2011
6222011
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor …
AU Buzdar, V Valero, NK Ibrahim, D Francis, KR Broglio, RL Theriault, ...
Clinical Cancer Research 13 (1), 228-233, 2007
6042007
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2–positive, node-negative tumors 1 cm or smaller
AM Gonzalez-Angulo, JK Litton, KR Broglio, F Meric-Bernstam, R Rakkhit, ...
Journal of clinical oncology 27 (34), 5700-5706, 2009
5732009
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
E Devarajan, AA Sahin, JS Chen, RR Krishnamurthy, N Aggarwal, ...
Oncogene 21 (57), 8843-8851, 2002
5712002
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ
E Half, XM Tang, K Gwyn, A Sahin, K Wathen, FA Sinicrope
Cancer research 62 (6), 1676-1681, 2002
5332002
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks
MC Green, AU Buzdar, T Smith, NK Ibrahim, V Valero, MF Rosales, ...
Journal of Clinical Oncology 23 (25), 5983-5992, 2005
5142005
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy
BT Hennessy, GN Hortobagyi, R Rouzier, H Kuerer, N Sneige, AU Buzdar, ...
Journal of Clinical Oncology 23 (36), 9304-9311, 2005
5112005
The system can't perform the operation now. Try again later.
Articles 1–20